159 related articles for article (PubMed ID: 3818134)
21. Sequestration of serotonin in stored platelets.
Shimizu T; Kato K
Transfusion; 1986; 26(3):274-7. PubMed ID: 3705147
[TBL] [Abstract][Full Text] [Related]
22. Serotonin, hypertension and vascular disease.
Vanhoutte PM
Neth J Med; 1991 Feb; 38(1-2):35-42. PubMed ID: 2030808
[TBL] [Abstract][Full Text] [Related]
23. Selective reduction of serotonin storage and ATP release in chronic renal failure patients platelets.
Soslau G; Brodsky I; Putatunda B; Parker J; Schwartz AB
Am J Hematol; 1990 Nov; 35(3):171-8. PubMed ID: 2220759
[TBL] [Abstract][Full Text] [Related]
24. 5HT-kinetics and sensitivity of human blood platelets: variations with age, gender and platelet number.
Fetkovska N; Amstein R; Ferracin F; Regenass M; Bühler FR; Pletscher A
Thromb Haemost; 1988 Dec; 60(3):486-90. PubMed ID: 2467403
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin.
Ziu E; Mercado CP; Li Y; Singh P; Ahmed BA; Freyaldenhoven S; Lensing S; Ware J; Kilic F
J Mol Cell Cardiol; 2012 May; 52(5):1112-21. PubMed ID: 22366712
[TBL] [Abstract][Full Text] [Related]
26. The role of serotonin in cardiovascular diseases and their treatment.
van Zwieten PA; Blauw GJ; van Brummelen P
Cardiovasc Drugs Ther; 1990 Dec; 4(6):1443-7. PubMed ID: 2081137
[TBL] [Abstract][Full Text] [Related]
27. An assessment of platelet aggregation induced by 5-hydroxytryptamine.
Hilton BP; Cumings JN
J Clin Pathol; 1971 Apr; 24(3):250-8. PubMed ID: 5573439
[TBL] [Abstract][Full Text] [Related]
28. The platelet serotonergic system in depression and following sertraline treatment.
Butler J; Leonard BE
Int Clin Psychopharmacol; 1988 Oct; 3(4):343-7. PubMed ID: 3235819
[TBL] [Abstract][Full Text] [Related]
29. Lack of inhibition of thrombin-induced rise in intracellular Ca2+ levels and 5-hydroxytryptamine secretion by 1-oleoyl-2-acetylglycerol in human platelets.
Krishnamurthi S; Joseph SK; Kakkar VV
FEBS Lett; 1986 Feb; 196(2):365-9. PubMed ID: 3949008
[TBL] [Abstract][Full Text] [Related]
30. Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood platelets.
Affolter H; Burkard WP; Pletscher A
Eur J Pharmacol; 1985 Jan; 108(2):157-62. PubMed ID: 3156755
[TBL] [Abstract][Full Text] [Related]
31. Increase in density and accumulation of serotonin by human aging platelets.
Mezzano D; Aranda E; Rodríguez S; Foradori A; Lira P
Am J Hematol; 1984 Jul; 17(1):11-21. PubMed ID: 6741929
[TBL] [Abstract][Full Text] [Related]
32. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
[TBL] [Abstract][Full Text] [Related]
33. Contribution of gene-modified mice and rats to our understanding of the cardiovascular pharmacology of serotonin.
Monassier L; Laplante MA; Ayadi T; Doly S; Maroteaux L
Pharmacol Ther; 2010 Dec; 128(3):559-67. PubMed ID: 20828585
[TBL] [Abstract][Full Text] [Related]
34. Re-evaluation of the uptake of desoxyfructo-serotonin by human platelets, and of its effect on the uptake of serotonin.
Costa JL; Kirk KL
Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):79-88. PubMed ID: 451361
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of agonist-induced platelet aggregation, Ca2+ mobilization and granule secretion by guanosine 5'-[beta-thio]diphosphate and GDP in intact platelets. Evidence for an inhibitory mechanism unrelated to the inhibition of G-protein-GTP interaction.
Krishnamurthi S; Patel Y; Kakkar VV
Biochem J; 1988 Feb; 250(1):209-14. PubMed ID: 3355512
[TBL] [Abstract][Full Text] [Related]
36. Effects of chlorprothixene isomers on platelet 5-hydroxytryptamine receptors: evidence for different 5-hydroxytryptamine conformations at uptake and stimulatory sites.
Drummond AH; Whigham KA; Prentice CR
Eur J Pharmacol; 1976 Jun; 37(2):385-8. PubMed ID: 954816
[TBL] [Abstract][Full Text] [Related]
37. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
Marney SR; Colley DG; Des Prez RM
J Immunol; 1975 Feb; 114(2 Pt 1):696-703. PubMed ID: 804512
[TBL] [Abstract][Full Text] [Related]
38. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
Ganey PE; Roth RA
Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
[TBL] [Abstract][Full Text] [Related]
39. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW
Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700
[TBL] [Abstract][Full Text] [Related]
40. The role of platelet prostanoids and dense granule compounds in initial attachment, spreading and aggregation of platelets on collagen substrates.
Leytin VL; Misselwitz F; Lyubimova EV; Domogatsky SP
Thromb Res; 1989 Aug; 55(4):395-406. PubMed ID: 2814935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
